Posts Tagged ‘innovation’

During the pandemic, telemedicine visits grew from 0.15 percent of all visits to 13 percent. That’s a big increase – almost 100-fold – from a very small base. But the real question is will this new habit stick? As with many ways we adapted, telemedicine has some advantages. Especially in obesity care, telemedicine seems to […]

We are on the cusp of great progress for anti-obesity medicines. Writing in Cell Metabolism, Fiona Gribble and Stephen O’Rahilly call it the end of the beginning. They have high hopes for new medications to treat obesity – one of the most common and difficult chronic diseases we face. But these advances fly in the […]

If you had any doubt about prior reports that semaglutide is likely to be a “game changer” for obesity care, perhaps you should look at JAMA today. Just one month after another paper in JAMA, semaglutide is back in the journal. This time, it is a 68-week study that shows the value of maintaining therapy […]

“Medical care is nice, but it’s surely not the answer to obesity. Behaviors matter.” These words came to us from the audience of a webinar for a regional business group on health. Oddly enough, those words came on the same day that JAMA published yet another major study on semaglutide for treating obesity. Two weeks […]

When NEJM recently published impressive results for a new obesity treatment, it caused quite a stir. Now it looks like semaglutide might have some serious competition coming right behind it. Late last week, Lilly announced results for two phase 3 studies of tirzepatide. These were both studies for type-2 diabetes. Effects on body weight were […]

Innovation in obesity care has come a long way. Back in 2010, Sanofi was smarting from the spectacular failure of rimonabant and big pharma was closing down research programs in obesity. But Novo Nordisk forged ahead with an ambitious program and now has a successful portfolio in obesity care to show for it. Nonetheless, we […]

China is going to eliminate food waste and fight obesity in a single stroke of regulation. How, you ask? Operation Empty Plate will expand into law. China will make it a crime to promote food waste, including overeating. The hilarity of naive efforts to regulate food marketing never disappoints. Stiff Fines for Bad Marketing Right […]

News from Eli Lilly and Company suggests that we may soon see a new drug that offers two-for-one efficacy – a clinical benefit in both obesity and diabetes. The company announced yesterday that tirzepatide produced good results against endpoints for both diseases in a phase 3 RCT. In this study, called SURPASS-1, researchers tested three […]

Friday marked an important milestone in progress toward better treatments for obesity. Novo Nordisk submitted semaglutide to FDA for approval in treating obesity. So we may see approval for this important new drug in the second half of next year. Why so important? We have two reasons. A Step Forward in Effectiveness The first reason […]

This is the ultimate Friday news dump. FDA approved a highly innovative, highly targeted treatment for obesity – setmelanotide – Wednesday night. Just before a four-day holiday. The company announced in on Friday – timing one would typically choose for news they want to hide. But this is really good news for the treatment of […]